Fresenius SE & Co KGaA (FSNUY)
8.78
+0.16
(+1.86%)
USD |
OTCM |
Nov 15, 16:00
Fresenius Total Liabilities (Quarterly): 25.65B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 25.65B |
June 30, 2024 | 25.63B |
March 31, 2024 | 26.10B |
December 31, 2023 | 28.33B |
September 30, 2023 | 47.68B |
June 30, 2023 | 48.88B |
March 31, 2023 | 48.39B |
December 31, 2022 | 47.38B |
September 30, 2022 | 45.38B |
June 30, 2022 | 46.04B |
March 31, 2022 | 47.47B |
December 31, 2021 | 48.32B |
September 30, 2021 | 49.75B |
June 30, 2021 | 50.60B |
March 31, 2021 | 48.59B |
December 31, 2020 | 49.96B |
September 30, 2020 | 49.45B |
June 30, 2020 | 47.58B |
March 31, 2020 | 46.34B |
December 31, 2019 | 45.28B |
September 30, 2019 | 43.83B |
June 30, 2019 | 44.96B |
March 31, 2019 | 43.97B |
December 31, 2018 | 36.26B |
September 30, 2018 | 36.86B |
Date | Value |
---|---|
June 30, 2018 | 36.67B |
March 31, 2018 | 38.81B |
December 31, 2017 | 37.69B |
September 30, 2017 | 37.62B |
June 30, 2017 | 36.47B |
March 31, 2017 | 34.73B |
December 31, 2016 | 27.33B |
September 30, 2016 | 26.80B |
June 30, 2016 | 26.98B |
March 31, 2016 | 26.61B |
December 31, 2015 | 26.25B |
September 30, 2015 | 27.16B |
June 30, 2015 | 27.58B |
March 31, 2015 | 27.06B |
December 31, 2014 | 28.73B |
September 30, 2014 | 28.23B |
June 30, 2014 | 29.06B |
March 31, 2014 | 27.79B |
December 31, 2013 | 26.27B |
September 30, 2013 | 23.34B |
June 30, 2013 | 22.94B |
March 31, 2013 | 22.53B |
December 31, 2012 | 23.15B |
September 30, 2012 | 22.84B |
June 30, 2012 | 23.06B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
25.63B
Minimum
Jun 2024
50.60B
Maximum
Jun 2021
43.64B
Average
47.52B
Median
Total Liabilities (Quarterly) Benchmarks
Affimed NV | 26.22M |
InflaRx NV | 16.09M |
BioNTech SE | 3.671B |
Immatics NV | 256.27M |
CureVac NV | 193.27M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 47.32B |
Shareholders Equity (Quarterly) | 21.03B |
Debt to Equity Ratio | 0.6278 |
Current Ratio | 1.356 |
Net Debt Paydown Yield | 9.70% |